Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Illumina; Rosetta Genomics; Chronix Biomedical; Caris Life Sciences; Babraham Institute

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Illumina announced this week that it has cut the price on its individual genome sequencing service to $19,500. The firm also said that the price would be $14,500 per genome for groups of five participants using the same physician. Last June, Illumina partnered with four consumer genomics firms to bring whole-genome sequencing analysis of genetic risk information to customers. The initial cost of the service was $48,000.

Rosetta Genomics this week formed a majority-owned subsidiary called Rosetta Green, which is focused on microRNA-based agricultural and clean technology applications. Rosetta said that it holds a 76 percent stake in the new subsidiary. Rosetta Green also has received $1.5 million in funding from outside investors and has received funding from the Israeli Office of the Chief Scientist.

Chronix Biomedical said that it has launched a new disease detection and monitoring service for cancer researchers using its Apoptotic DNA Blood Test, which analyzes apoptotic DNA from dead and dying cells to identify and track ongoing changes associated with specific cancers and other chronic diseases.

Caris Life Sciences said this week that it has moved into a new corporate headquarters in the Dallas area that is three times larger than its previous facility. It also said that it has tripled its space in Phoenix with a new facility that conducts R&D on molecular tests for cancer.

Researchers at the Babraham Institute have been awarded a £900,000 ($1.3 million) grant to conduct studies in epigenetic regulation in partnership with biotech firm CellCentric. The funding is being provided by the UK's Biotechnology and Biological Sciences Research Council.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.